Slc7a7 disruption causes fetal growth retardation by downregulating Igf1 in the mouse model of lysinuric protein intolerance

American Journal of Physiology - Cell Physiology

Volumn 293, Issue 1, 2007, Pages

  Sperandeo, Maria Pia ^a   Annunziata, Patrizia ^a   Bozzato, Andrea ^b   Piccolo, Pasquale ^a   Maiuri, Luigi ^c   D'Armiento, Maria ^a   Ballabio, Andrea ^a,d   Corso, Gaetano ^c   Andria, Generoso ^a   Borsani, Giuseppe ^b   Sebastio, Gianfranco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

Cationic amino acid transport; Hyperdibasicaminoaciduria; Neonatal lethality

Indexed keywords

CARRIER PROTEIN; DNA; LYSINE; PROTEIN SLC7A7; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EMBRYONIC STEM CELL; FETUS; FETUS LIVER; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MUTATION; HIGH THROUGHPUT SCREENING; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; MOUSE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTOLERANCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACID METABOLISM, INBORN ERRORS; AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; ARGININE; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FETAL GROWTH RETARDATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOTYPE; INSULIN-LIKE GROWTH FACTOR I; INTESTINES; LIVER; LYSINE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; UREA;

ANIMALIA; MUS;

EID: 34547133472     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00583.2006     Document Type: Article

References (31)

1. Ben Lagha N, Seurin D, Le Bouc Y, Binoux M, Berdal A, Menuelle P, Babajko S. Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice. Endocrinology 147: 4730-4737, 2006.
2. Bienvenu G, Seurin D, Grellier P, Froment P, Baudrimont M, Monget P, Le Bouc Y, Babajko S. Insulin-like growth factor binding protein-6 transgenic mice: postnatal growth, brain development, and reproduction abnormalities. Endocrinology 145: 2412-2420, 2004.
3. Borsani G, Bassi MT, Sperandeo MP, De Grandi A, Buoninconti A, Riboni M, Manzoni M, Incerti B, Pepe A, Andria G, Ballabio A, Sebastio G. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nat Genet 21: 297-301, 1999.
4. Chevalley T, Rizzoli R, Manen D, Caverzasio J, Bonjour JP. Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells. Bone 23: 103-109, 1998.
5. Duan C, Xu Q. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 142: 44-52, 2005.
6. Esposito V, Lettiero T, Fecarotta S, Sebastio G, Parenti G, Salerno M. Growth hormone deficiency in a patient with lysinuric protein intolerance. Eur J Pediatr 165: 763-766, 2006.
7. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80, 2004.
8. Hoeflich A, Wu M, Mohan S, Foll J, Wanke R, Froehlich T, Arnold GJ, Lahm H, Kolb HJ, Wolf E. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140: 5488-5496, 1999.
9. Kaufman MH. The Atlas of Mouse Development. New York: Academic Press, 2002.
10. Klempt M, Hutchins AM, Gluckman PD, Skinner SJ. GF binding protein-2 gene expression and the location of IGF-I and IGF-II in fetal rat lung. Development 115: 765-772, 1992.
11. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72, 1993.
12. McClive PJ, Sinclair AH. Rapid DNA extraction and PCR-sexing of mouse embryos. Mol Reprod Dev 60: 225-226, 2001.
13. Mesotten D, Delhanty PJ, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van Den Berghe G. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87: 5516-5523, 2002.
14. Nyomba BL, Berard L, Murphy LJ. Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab 82: 2177-2181, 1997.
15. Palacin M, Borsani G, Sebastio G. The molecular bases of cystinuria and lysinuric protein intolerance. Curr Opin Genet Dev 11: 328-335, 2001.
16. Pfeiffer R, Rossier G, Spindler B, Meier C, Kuhn L, Verrey F. Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. EMBO J 18: 49-57, 1999.
17. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA. IGF-I is required for normal embryonic growth in mice. Genes Dev 7: 2609-2617, 1993.
18. Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347: 983-991, 2002.
19. +L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance. Hum Mutat 20: 375-378, 2002.
20. Simell O. Lysinuric protein intolerance and other cationic aminoacidurias. In: The Metabolic & Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, and Valle DT. New York: McGraw-Hill, 2001.
21. Smyth GK. Linear models, and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article 3, 2004.
22. +LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance. Eur J Hum Genet 13: 628-634, 2005.
23. Sperandeo MP, Annunziata P, Ammendola V, Fiorito V, Pepe A, Soldovieri MV, Taglialatela M, Andria G, Sebastio G. Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene. Hum Mutat 25: 410, 2005.
24. Takiguchi M, Mori M. Transcriptional regulation of genes for ornithine cycle enzymes. Biochem J 15: 649-659, 1995.
25. Tanner L, Nanto-Salonen K, Niinikoski H, Erkkola R, Huoponen K, Simell O. Hazards associated with pregnancies and deliveries in lysinuric protein intolerance. Metabolism 55: 224-231, 2006.
26. +L. A candidate gene for lysinuric protein intolerance. J Biol Chem 273: 32437-32445, 1998.
27. +LAT-1, as the lysinuric protein intolerance gene. Nat Genet 21: 293-296, 1999.
28. Verhaeghe J, Loos R, Vlietinck R, Herck EV, van Bree R, Schutter AM. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in cord serum of twins: genetic versus environmental regulation. Am J Obstet Gynecol 175: 1180-1188, 1996.
29. Verhaeghe J, Billen J, Giudice LC. Insulin-like growth factor-binding protein-1 in umbilical artery and vein of term fetuses with signs suggestive of distress during labor. J Endocrinol 170: 585-590, 2001.
30. i) transporter (SLC34A2). Genomics 62: 281-284, 1999.
31. Zambrowicz BP, Friedrich GA, Buxton EC, Lilleberg SL, Person C, Sands AT. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 392: 608-611, 1998.